Biotech Grants & R&D Tax for Biotech: Fueling UK Life Sciences Innovation

The UK’s biotech sector plays a pivotal role in delivering breakthrough healthcare solutions, from next-generation therapeutics to synthetic biology and precision diagnostics. To accelerate innovation in this high-risk, high-reward field, the government offers a range of biotech grants and R&D tax relief opportunities.

FI Group supports biotech firms across the full funding landscape — from securing innovation grants to maximising R&D tax credits. Our PhD-level consultants combine scientific insight with technical tax expertise to help companies navigate the complexities of biotech funding in the UK.

R&D in the Biotech Sector: What Qualifies?

The life sciences sector is defined by continuous research and experimentation. Common areas of qualifying R&D activity include:

• Preclinical drug development and optimisation
• Molecular biology, immunology, and genomics research
• Development of medical devices or diagnostic platforms
• Process scale-up, fermentation and biomanufacturing
• Overcoming regulatory, stability or scalability barriers

If your project seeks to resolve scientific or technological uncertainties and involves systematic investigation, it is likely to qualify under HMRC’s R&D criteria.